VP45.29: Effectiveness of low‐dose hydroxychloroquine versus placebo for the prevention of severe pneumonia in pregnant women with SARS‐CoV2 infection: PROTOCOL for a randomised controlled trial (HYPREG trial)

類似資料

• OC04.05: The interwoven effect of maternal age and co‐morbidities in COVID‐19 fatality among pregnant women: the Mexican national cohort
  著者:: Martinez‐Portilla, R.J., 等
  出版事項: (2020)
• VP45.21: Clinical correlation of severe and non‐severe infection by SARS‐CoV2 in pregnant women
  著者:: Torres‐Torres, J., 等
  出版事項: (2020)
• VP45.26: Pregnant patient infected by SARS‐CoV2: management protocol in the delivery room of the General Hospital of Mexico
  著者:: Torres‐Torres, J., 等
  出版事項: (2020)
• VP45.03: COVID‐19 causing HELLP‐like syndrome in pregnancy and the role of angiogenic factors for differential diagnosis
  著者:: Figueras, F., 等
  出版事項: (2020)
• Hydroxychloroquine Controversies: Clinical Trials, Epistemology, and the Democratization of Science
  著者:: Berlivet, Luc, 等
  出版事項: (2020)